Nephros (NEPH) Operating Margin (2010 - 2026)

Nephros has reported Operating Margin for 17 years, with the latest figure at 20.16% in Q2 2026.

• On a quarterly basis, Operating Margin rose 1455.0% year-over-year to 20.16% in Q2 2026; TTM through Jun 2026 was 7.92%, a 9.0% decrease from a year earlier, with the FY2025 full-year figure at 6.1%, up 606.0% from the prior year.
• Operating Margin was 20.16% for Q2 2026 at Nephros, up from 1.86% in the prior quarter.
• The five-year high for Operating Margin was 20.16% in Q2 2026, with the low at 71.65% in Q1 2022.
• Average Operating Margin over 5 years is 10.09%, with a median of 5.55% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Margin slumped 3445 bps in 2022, then surged 6338 bps in 2023.
• Over 5 years, Operating Margin stood at 27.09% in 2022, then increased by 26 bps to 19.94% in 2023, then surged by 141 bps to 8.19% in 2024, then sank by 95 bps to 0.38% in 2025, then soared by 5196 bps to 20.16% in 2026.
• The last three Operating Margin figures came in at 20.16% (Q2 2026), 1.86% (Q1 2026), and 0.38% (Q4 2025), per Business Quant data.